Literature DB >> 34166828

Does COVID-19 Affect Survival and Functional Outcome in Emergency and Urgent Neurosurgical Procedures? A Single-Center Prospective Experience During the Pandemic.

Giorgio Fiore1, Luigi Gianmaria Remore2, Leonardo Tariciotti2, Giorgio Giovanni Carrabba3, Luigi Schisano2, Mauro Pluderi3, Giulio Andrea Bertani3, Stefano Borsa3, Marco Locatelli4.   

Abstract

OBJECTIVE: To assess organizational and technical difficulties of neurosurgical procedures during the coronavirus disease 2019 (COVID-19) pandemic and their possible impact on survival and functional outcome and to evaluate virological exposure risk of medical personnel.
METHODS: Data for all urgent surgical procedures performed in the COVID-19 operating room were prospectively collected. Preoperative and postoperative variables included demographics, pathology, Karnofsky performance status (KPS) and neurological status at admission, type and duration of surgical procedures, length of stay, postoperative KPS and functional outcome comparison, and destination at discharge. We defined 5 classes of pathologies (traumatic, oncological, vascular, infection, hydrocephalus) and 4 surgical categories (burr hole, craniotomy, cerebrospinal fluid shunting, spine surgery). Postoperative SARS-CoV-2 infection was checked in all the operators.
RESULTS: We identified 11 traumatic cases (44%), 4 infections (16%), 6 vascular events (24%), 2 hydrocephalus conditions (8%), and 2 oncological cases (8%). Surgical procedures included 11 burr holes (44%), 7 craniotomies (28%), 6 cerebrospinal fluid shunts (24%), and 1 spine surgery (4%). Mean patient age was 57.8 years. The most frequent clinical presentation was coma (44 cases). Mean KPS score at admission was 20 ± 10, mean surgery duration was 85 ± 63 minutes, and mean length of stay was 27 ± 12 days. Mean KPS score at discharge was 35 ± 25. Outcome comparison showed improvement in 16 patients. Four patients died. Mean follow-up was 6 ± 3 months. None of the operators developed postoperative SARS-CoV-2 infection.
CONCLUSIONS: Standardized protocols are mandatory to guarantee a high standard of care for emergency and urgent surgeries during the COVID-19 pandemic. Personal protective equipment affects maneuverability, dexterity, and duration of interventions without affecting survival and functional outcome.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  COVID-19; Neurosurgery; Neurosurgical outcome; SARS-CoV-2 infection; Urgent surgery

Year:  2021        PMID: 34166828      PMCID: PMC8216838          DOI: 10.1016/j.wneu.2021.06.071

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


Introduction

The coronavirus disease 2019 (COVID-19) pandemic caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus is still raging worldwide. Health care systems all over the world have to cope with COVID-19, with hospitals being forced to reorganize and direct their resources, in terms of both medical personnel and equipment, to dedicated COVID-19 units. Many departments reduced their activity; this was especially true for surgical departments: elective surgeries were canceled or rescheduled, while emergent surgeries were performed under selective indications and following standardized protocols.2, 3, 4, 5 In Italy, Lombardy, in northern Italy, was the first and most affected region by the COVID-19 pandemic in 2020. Our university hospital in Milan was organized as a COVID-19 hub, admitting SARS-COV-2–positive patients with clinical and surgical disorders. In this setting, elective surgeries for SARS-COV-2–positive patients with neurosurgical pathologies were waived until a COVID-19–negative result was obtained; consequently, the overall elective caseload of our division was reduced by Italian and regional regulations and laws. However, urgent surgical procedures were guaranteed through a dedicated COVID-19 operating room (OR). In the present study, the outcome of all urgent and emergency neurosurgical procedures was analyzed and reported. This study also addressed considerations regarding organizational and technical surgical difficulties and their possible impact on survival and functional outcome and analyzed the virological exposure risk of medical personnel.

Materials and Methods

Ethical approval was waived by the local Ethics Committee of the University of Milan because all the procedures being performed were part of routine care. We prospectively collected data from our electronic database for all urgent surgical procedures being performed in the COVID-19–dedicated OR. The following preoperative and postoperative variables were gathered: demographics, pathology, Karnofsky performance status (KPS) and neurological status at admission, surgical procedure types and their duration, hospital length of stay (LOS), KPS at discharge (postoperative KPS) and functional outcome comparison, and discharge destination. We defined 5 classes of pathologies: traumatic, oncological, vascular, infection, and hydrocephalus. The KPS score at admission was calculated and registered for all patients enrolled in the study. Neurological impairment at admission was defined as 1) mild, in patients with slight cognitive impairment without focal neurological deficits; 2) severe, in patients with focal neurological deficits; 3) coma, in patients with a Glasgow Coma Scale score <9. Surgical procedures were placed in 4 categories: burr hole (BH), craniotomy, cerebrospinal fluid (CSF) shunting (including external ventricular drain, ventriculoperitoneal shunt, and shunt revision), and spine surgery. Functional outcome was classified as improved, unchanged, and worsened based on preoperative and postoperative KPS score. The discharge destination was identified as follows: 1) home, 2) rehabilitation, 3) hospice, and 4) deceased. The risk of virological exposure of operators was assessed. The appearance of COVID-19 typical symptoms in association with SARS-CoV-2 nasopharyngeal swab positivity was collected during the 10 days following the surgical procedure.

Management of COVID-19 Patients in Our COVID-19 Hub and COVID-19 OR Organization

Our COVID-19 hub was organized so that patients with possible SARS-CoV-2 infection were screened by telehealth: a trained physician delivered a questionnaire regarding COVID-19–related symptoms and their severity to paramedics by telephone. Patients with more severe COVID-19 symptoms were admitted to the emergency department, where they underwent a molecular nasopharyngeal swab test and waited for the result in a dedicated area called the gray zone. Patients with a negative swab received standard care with no COVID-19 protocols, while patients with a positive swab were transferred to the COVID-19 ward, which was organized into 3 levels of severity: green, yellow, or red. Patients in critical condition requiring intubation underwent nasopharyngeal swab and a bronchoalveolar lavage. In case of emergency and urgent surgeries, patients were operated on in a dedicated COVID-19 OR. This OR was a negative pressure surgical room set up in the emergency department. All medical personnel wore specific personal protective equipment (PPE). Disposable medical protective uniforms and shoe coverings were available before entering the COVID-19 OR. Operators had to wear 2 pairs of latex or nitrile gloves, an N95 medical protective mask with a surgical mask over it, a surgical cap, and a plastic face shield. According to published surgical guidelines, procedures at risk for aerosolizing viral particles, such as high-speed drilling, were limited. The medical personnel left the OR via a separate clean pathway only after removing PPE according to a standardized protocol. To avoid undesirable contamination after surgery, instructions about the correct disposal of PPE were displayed and followed.

Statistical Analysis

Quantitative data were tested for normality. Normal variables were reported as mean ± SD and compared by Student t test. Categorical variables were reported as absolute counts (percentages), and intergroup comparison was computed using Fisher exact test or χ2 test. For all hypotheses, P values < 0.05 were considered statistically significant.

Results

We prospectively collected data of 25 emergency and urgent surgical procedures of SARS-CoV-2–positive patients performed at our institution in the COVID-19–dedicated OR. Patient population characteristics are summarized in Table 1 . Preoperative and postoperative variables for each patient are presented in Tables 2 and 3 . Complications are reported in Table 4 .
Table 1

Patient Characteristics

PrevalencePreoperative KPSSurgery Duration (minutes)LOS (days)Postoperative KPSComplicationsFU (months)
Pathologies
 Traumatic1120 ± 1590 ± 6519 ± 1140 ± 3075 ± 2
 Infection420 ± 1566 ± 2644 ± 1740 ± 1545 ± 3
 Oncological220142 ± 158233026
 Vascular61065 ± 4734 ± 515 ± 1568 ± 2
 Hydrocephalus210105 ± 641250212
Surgical procedure
 BH1125 ± 1555 ± 3127 ± 1745 ± 2574 ± 3
 Craniotomy715 ± 10155 ± 6830 ± 840 ± 2075 ± 3
 CSF shunting61060 ± 4626 ± 1140 ± 1069 ± 3
 Spine surgery13080383019

KPS, Karnofsky performance status; LOS, length of stay; FU, follow-up; BH, burr hole; CSF, cerebrospinal fluid.

Number of patients with any complication type (see Table 4 for more information).

Table 2

Preoperative Variables

PatientAge (years)/SexType of PathologyPathologyType of SurgeryPreoperative Neurological StatusPreoperative KPS
147/FTraumaCSDHBHConfused, hemisyndrome50
257/MTraumaCSDHBHAphasic, hemisyndrome40
360/MInfectionBrain abscessCraniotomyAphasic, hemisyndrome40
481/FTraumaCSDHBHAphasic, hemisyndrome40
51/MHydrocephalusObstructive hydrocephalusCSF shuntingComa10
61/MHydrocephalusShunt malfunctionCSF shuntingComa10
775/MInfectionBrain abscessBHAphasic, hemiparetic, seizures10
875/MInfectionBrain abscessBHAphasic, hemiparetic, seizures10
957/MOncologyHGGBHHemisyndrome20
1057/MOncologyHGGCraniotomyHemisyndrome20
1183/MTraumaCSDHBHAphasic, hemisyndrome30
1283/MTraumaCSDHBHAphasic, incoming seizures10
1383/MTraumaCSDHBHAphasic, incoming seizures10
1478/FTraumaCSDHBHConfused, hemisyndrome30
1582/FTraumaCSDHBHAphasic, hemisyndrome30
1652/MVascularCerebellar hemorrhageCSF shuntingComa10
1750/FVascularSAHCSF shuntingComa10
1858/MInfectionLumbar epidural empyemaSpinal surgeryParaparesis30
1933/MTraumaGunshot brain injuryCraniotomyComa10
2059/MVascularCerebellar hemorrhageCSF shuntingComa10
2149/MTraumaAEHCraniotomyComa10
2271/FVascularICHCraniotomyComa10
2354/FVascularSAHCSF shuntingComa10
2445/MVascularICHCraniotomyComa10
2554/MTraumaASDHCraniotomyComa10

KPS, Karnofsky performance status; F, female; CSDH, chronic subdural hematoma; BH, burr hole; M, male; CSF, cerebrospinal fluid; HGG, high-grade glioma; SAH, subarachnoid hemorrhage; AEH, acute epidural hematoma; ICH, intracerebral hemorrhage; ASDH, acute subdural hematoma.

Table 3

Postoperative Variables

PatientSurgery Time (minutes)LOS (days)Discharge DestinationKPS at DischargeOCFU (months)
1606Home100Improved3
28514Home90Improved4
39522Home60Improved3
41359Home50Improved8
56012Home50Improved12
615012Home50Improved12
75057Rehabilitation30Improved3
84057Rehabilitation30Improved3
93023Rehabilitation30Improved6
1025423Rehabilitation30Improved6
113023Rehabilitation30Unchanged2
123523Rehabilitation30Improved2
133023Rehabilitation30Improved2
144523Rehabilitation30Unchanged4
156039Rehabilitation30Unchanged10
166025Rehabilitation30Improved8
172635Rehabilitation30Improved8
188038Rehabilitation30Unchanged9
1921028Home50Improved3
204635Rehabilitation30Improved3
219525Hospice10Unchanged6
2280Deceased
2325Deceased
24150Deceased
25200Deceased

LOS, length of stay; KPS, Karnofsky performance status; OC, outcome comparison; FU, follow-up.

Table 4

Patient Complications

PatientType of Complication
COVID-19InfectiousSurgicalNeurologicalOthers
1
2Phlebitis
3PEBacterial pneumoniaHyperglycemia
4
5Shunt malfunctionComa
6Drug-resistant seizures
7PneumoniaBacterial pneumoniaNew drainageDrug-resistant seizures
8PneumoniaSepsis
9PneumoniaBacterial pneumoniaHyponatremia
10Persistent positivityFever
11CSDH relapseWorsening hemiparesis
12Drug-resistant seizures
13
14
15Multidrug resistant bacterial colonizationAF
16Bacterial pneumonia
17Bacterial pneumoniaHydrocephalus
18SpondylodiscitisArthrodesisPleural effusion
19Bacterial pneumonia
20ARDS, DVT
21SepsisHRS
22Death
23Death
24Death
25Death

COVID-19, coronavirus disease 2019; PE, pulmonary embolism; CSDH, chronic subdural hematoma; AF, atrial fibrillation; ARDS, acute respiratory distress syndrome; DVT, deep venous thrombosis; HRS, hepatorenal syndrome.

Patient Characteristics KPS, Karnofsky performance status; LOS, length of stay; FU, follow-up; BH, burr hole; CSF, cerebrospinal fluid. Number of patients with any complication type (see Table 4 for more information). Preoperative Variables KPS, Karnofsky performance status; F, female; CSDH, chronic subdural hematoma; BH, burr hole; M, male; CSF, cerebrospinal fluid; HGG, high-grade glioma; SAH, subarachnoid hemorrhage; AEH, acute epidural hematoma; ICH, intracerebral hemorrhage; ASDH, acute subdural hematoma. Postoperative Variables LOS, length of stay; KPS, Karnofsky performance status; OC, outcome comparison; FU, follow-up. Patient Complications COVID-19, coronavirus disease 2019; PE, pulmonary embolism; CSDH, chronic subdural hematoma; AF, atrial fibrillation; ARDS, acute respiratory distress syndrome; DVT, deep venous thrombosis; HRS, hepatorenal syndrome. We identified 11 traumatic cases (44%), 4 infection cases (16%), 6 vascular cases (24%), 2 hydrocephalus cases (8%), and 2 oncological cases (8%). The surgical procedures included 11 BHs (44%), 7 craniotomies (28%), 6 CSF shunts (24%), and 1 spine surgery (4%). The mean age of patients was 57.8 years, and 7 patients were female. The most frequent clinical presentation was coma (11 patients, 44%), followed by severe neurological impairment (8 patients). The mean KPS score at admission was 20 ± 10, mean surgery duration was 85 ± 63 minutes, and mean LOS was 27 ± 12 days. Seven patients were discharged to home, 13 patients were transferred to a rehabilitation center, and 1 patient was transferred to a hospice. The mean KPS score at discharge for these patients was 35 ± 25. The outcome comparison was improved for 16 patients and unchanged for 5 patients. Four patients in our series died. The mean follow-up was 6 ± 3 months.

Pathology Types

Traumatic

The 11 traumatic cases included 8 chronic subdural hematomas (73%), 1 acute subdural hematoma (9%), 1 acute epidural hematoma (9%), and 1 gunshot brain injury (9%). The mean age of trauma patients was 66 ± 19 years, and 7 (64%) were male. The majority of patients experienced mental deterioration (6 of 11, 54.5%), and the mean KPS score at admission was 20 ± 15. The most common surgical procedure performed was BH (7 of 11, 64%). The mean surgery duration was 90 ± 65 minutes, and the mean LOS was 19 ± 11 days. Most patients were referred to a rehabilitation facility (6 of 11, 55%) with a mean KPS score of 40 ± 30. The patient with acute subdural hematoma died.

Infection

Surgery was performed for infectious conditions in 4 patients: 3 brain abscesses (75%) and 1 lumbar epidural empyema (25%). The mean age of patients was 67 ± 9 years, and all patients were male. The mean KPS score at admission was 20 ± 15. Severe neurological impairment was evident at the first clinical examination in 3 patients (75%). Guided navigation drainages through a BH were used for 2 patients (50%) with brain abscesses, while the third patient underwent surgical evacuation through a craniotomy. The patient with an epidural empyema underwent a lumbar laminectomy. The mean surgery duration was 66 ± 26 minutes, and the mean LOS was 44 ± 17 days. Three patients (75%) needed a postoperative hospitalization for rehabilitation. The patient who received the craniotomy was discharged to home. The mean KPS score at discharge was 40 ± 15.

Oncological

The single oncological case concerned a patient with a voluminous cystic intra-axial lesion (anaplastic astrocytoma, IDH wild-type, grade III World Health Organization); the patient underwent surgical drainage of the cystic component in emergency conditions and underwent a craniotomy the following day for surgical resection. The KPS score at admission was 20. The mean duration of the surgical procedures was 142 ± 158 minutes. The LOS was 23 days, during which temozolomide was administered when the patient tested negative for SARS-CoV-2. The temozolomide was stopped after 3 days because the patient was found to be SARS-CoV-2 positive again. The patient was discharged to home in a stable condition (KPS score 30).

Vascular

There were 6 cerebrovascular cases: 2 subarachnoid hemorrhages from aneurysmal rupture, 2 cerebellar hemorrhages, and 2 intracerebral hemorrhages. The mean age was 55 ± 9 years. Half of the patients were males (3 of 6, 50%). All patients were comatose at admission (KPS score 10). Four patients (66.6%) were subjected to a ventricular shunting procedure, and 2 (33.4%) underwent craniotomy. The mean surgery duration was 65 ± 47 minutes, and the mean LOS was 34 ± 5 days. Three of the patients were moved to a rehabilitation facility, with a mean KPS score of 15 ± 15, and 3 patients died.

Hydrocephalus

The last 2 surgical procedures concerned a 1-year-old male patient, who underwent 2 shunting procedures for ventriculoperitoneal shunt malfunction. Before either procedure, the patient was comatose (KPS score 10). The mean duration of surgeries was 105 ± 64 minutes. After 12 days in the pediatric ward, the patient was discharged to home with a KPS score of 50.

Surgical Procedures

Burr Hole

The mean age of patients who underwent BH was 73 ± 13 years, and 7 patients (64%) were male. This procedure was more frequently performed on patients with mental deterioration (6 of 11, 55%) at admission and a mean KPS score of 25 ± 15. The mean surgical time was 55 ± 31 minutes. The mean LOS was 27 ± 17 days, and rehabilitation was deemed necessary for the majority of patients (8 of 11, 73%). The mean postoperative KPS score was 45 ± 25.

Craniotomy

Craniotomy was more commonly performed for patients who were comatose at admission (5 of 7, 71%), with a mean KPS score of 15 ± 10. These patients were 53 ± 12 years old on average, and 6 of 7 were male. The mean duration of surgical procedures was 155 ± 68 minutes, and the mean LOS was 30 ± 8 days. Two patients were discharged to home, 1 patient was transferred to a rehabilitation facility, and 1 patient was transferred to a hospice. The mean KPS score at discharge was 40 ± 20. Three patients in this group died.

CSF Shunting

CSF shunting procedures were performed in 6 patients with a mean age of 36 ± 27 years, and the male-to-female ratio was 4:2. Coma was the clinical presentation for all 6 patients (KPS score 10). The mean surgical duration was 60 ± 46 minutes, and the mean LOS was 26 ± 11 days. Three patients were discharged to home, and 2 were referred to rehabilitation centers. The mean KPS score at discharge was 40 ± 10. One patient died.

Spinal Surgery

One patient underwent a lumbar laminectomy to drain an epidural empyema. The patient was a 58-year-old man who was admitted to the emergency department with a mild paraparesis (Medical Research Council muscle strength scale = 3/5), with a KPS score of 30. He was referred to a rehabilitation facility in stable neurological condition after a 38-day LOS. The LOS after surgery was statistically longer among infectious diseases cases (P = 0.01). Chances to be discharged to home were statistically higher in oncological cases (P = 0.03) and nonhemorrhagic hydrocephalus (P = 0.03). The KPS score at discharge was statistically improved compared with preoperative score (20 ± 10 vs. 35 ± 25; P < 0.001).

Discussion

Lombardy is the most populated region in Italy and one of the most affected by the COVID-19 pandemic. Therefore, the health care system in Lombardy was reorganized following the hub-and-spoke organizational model. A few hub centers accounting for specific pathologies and medical specialties were defined, while the remaining centers served as spokes referring patients to the hubs and managing patients with COVID-19 of low or intermediate severity. Our institution was a COVID-19 hub managing medical and surgical patients with highly severe COVID-19. In this environment, our neurosurgical unit limited elective surgeries to cases that could not be deferred and referred most of the non–COVID-19 traumatic and oncological cases to neurosurgical trauma and oncology hubs. We identified 25 SARS-CoV-2–positive surgical patients who underwent emergency and urgent surgeries in the dedicated COVID-19 OR. Although our sample population was small, paucity of data from available literature of systematically organized COVID-19 neurosurgical urgent case series might make this study useful to improve the management of such patients during this harsh pandemic that shows no signs of ending.9, 10, 11

Traumatic Cases

Traumatic cases were the most common, including 8 chronic subdural hematomas, 1 acute subdural hematoma, and 1 epidural hematoma. The prevalence of posttraumatic pathologies related to minor trauma could be explained by restricted mobility and outdoor activity, consequent to Italian government restrictions being imposed to limit the pandemic. Patients with posttraumatic pathologies showed the highest COVID-19 positivity rate. As trauma is the most common reason for emergency department admittance, these patients were more frequently subjected to nasopharyngeal swab testing.

Infection Cases

Patients with infectious pathologies frequently showed a serious clinical impairment requiring urgent or emergency treatment. Moreover, they spent more days in the hospital after surgery, which could be related to the need for long-term use of antibiotics that could not be administered at home.

Oncological Cases

The treatment of oncological disease in SARS-CoV-2–positive patients was delayed until patients became SARS-CoV-2 negative in most of our case series in 2020. Therefore, the oncological patient in the current study was not expected to survive without surgery (American Society of Anesthesiologists class V). The patient experienced a COVID-19 relapse after temozolomide administration. Again, COVID-19 presents physicians with an ethical difficulty. On one hand, is it right to administer chemotherapy, exposing oncological patients to the risks of COVID-19 relapse? On the other hand, is it right not to administer the only medical treatment available for patients with high-grade glioma because of the risk of COVID-19 relapse? The data present in the literature are too scarce to answer these questions, confirming the need to fill the gaps with further clinical experiences.

Vascular Cases

The cerebrovascular disease group was the second most represented in our series. Considering that only a small percentage of patients with cerebrovascular disorders require neurosurgical treatments, we are considering here only the tip of an iceberg that is composed of a multitude of patients with ischemic stroke or with hemorrhagic brain diseases not amenable to neurosurgical treatment (e.g., subarachnoid hemorrhages and intracerebral hemorrhages, often amenable to medical and endovascular treatments). Therefore, in agreement with a recent systematic review, cerebrovascular events are relatively common findings during the COVID-19 pandemic, with SARS-CoV-2 infection appearing to help trigger the vascular event. We registered the highest death rate among these patients. However, this is likely to be attributable to the deadly nature of cerebrovascular diseases rather than surgical treatment; all the deceased patients were comatose at admission.

CSF Shunting

CSF shunting procedures seemed to be the least influenced by the COVID-19 setting protocols. A possible explanation could be that patients needing an urgent CSF shunt received an external ventricular drain, which is a procedure with little susceptibility to dexterity limitations of surgical movements, in terms of both operative time and outcome.

Surgery Duration

Overall, the mean duration of the surgeries being performed in the COVID-19–dedicated OR was longer compared with the usual OR setting (data from electronic registers). According to an internal survey conducted in our neurosurgical unit, almost every surgeon reported some difficulties in the COVID-19 OR. Main difficulties concerned reduction in hand dexterity related to multiple pairs of gloves (2 disposable and 1 sterile) and poor visual acuity owing to tarnished face shields. These difficulties persisted in later surgeries and were independent of personal surgical expertise (attendants vs. residents).

Hospital LOS

An increased LOS was reported in this series. Dowlati et al. pointed out that patients with COVID-19 were more likely to develop an in-hospital complication other than the COVID-19 diagnosis. Likewise, about half of the patients in our series presented with an infectious disease complication. We share the impression from previous reports of a greater risk of neurosurgical patients with COVID-19 to experience longer-than-average hospital stay. Nonetheless, major hospitalization-related complications were not observed.

Survival and Functional Outcome

The outcome comparison in this series highlights no worsening of KPS at discharge compared with preoperative KPS. In our experience, the aforementioned technical difficulties imposed by the COVID-19–dedicated OR protocols seem not to have great repercussions on the surgical outcome except for the surgical duration. Moreover, none of the patients in our series died of COVID-19–related causes. Nonetheless, the postoperative functional outcome remains unsatisfactory. We think that it might be mainly attributable to the patient’s severity of clinical presentation at admission (e.g., the high percentage of comatose patients).

Virological Risk for Medical Personnel

None of the operators developed a postoperative SARS-CoV-2 infection. These reassuring data should increase the confidence of the health professionals involved in the pandemic: compliance with safety protocols is fundamental and effective in safeguarding their health.

Limitations

The main limitation of this study is the characteristics of the cohort, which is made up of a limited number of heterogeneous patients with serious clinical conditions. Nevertheless, SARS-CoV-2–positive neurosurgical patients are most often operated on with extreme urgency, likely having characteristics comparable to those of this series. Broader sample size is, in any case, desirable to reduce the heterogeneity and selection bias intrinsic to the inclusion of patients with different pathologies and subjected to different surgical procedures. Moreover, the findings of this study should be generalized to other institutions with a similar setting and a comparable experience with the pandemic.

Conclusions

The current surgical series reports the experience of a dedicated surgical COVID-19 center facing emergency and urgent surgical cases during the active phase of the COVID-19 pandemic. This case series suggests that standardized protocols for referral and in-hospital management are mandatory to guarantee a high standard of care in these emergency cases. For these reasons, neurosurgical COVID-19–positive cases should be referred to specialized centers such as the hubs defined in our region. PPE affects maneuverability, dexterity, and duration of interventions, according to dedicated surgical team witnesses and electronic registers; nonetheless, survival and overall functional outcome do not seem to be greatly affected by technical concerns. The absence of SARS-CoV-2 infections among the medical personnel is also worthy of being highlighted. Further investigations are needed to clarify the impact of SARS-CoV-2 on the management of urgent neurosurgical procedures.

CRediT authorship contribution statement

Giorgio Fiore: Methodology, Validation, Formal analysis, Investigation, Resources, Data curation, Writing - original draft, Writing - review & editing. Luigi Gianmaria Remore: Validation, Data curation, Formal analysis, Writing - original draft. Leonardo Tariciotti: Validation, Data curation, Formal analysis, Writing - review & editing, Supervision. Giorgio Giovanni Carrabba: Methodology, Validation, Data curation, Writing - review & editing, Supervision. Luigi Schisano: Validation, Data curation, Formal analysis, Writing - review & editing, Supervision. Mauro Pluderi: Methodology, Validation, Data curation, Writing - review & editing, Supervision. Giulio Andrea Bertani: Methodology, Validation, Data curation, Investigation, Writing - original draft, Writing - review & editing, Supervision. Stefano Borsa: Methodology, Validation, Data curation, Writing - original draft, Writing - review & editing, Supervision. Marco Locatelli: Methodology, Validation, Data curation, Writing - review & editing, Supervision.
  13 in total

1.  Safely performing neurosurgical procedures during COVID-19 pandemic.

Authors:  Laura K Reed; Jun Wen; Buqing Liang; Xiangyu Wang; Dongxia Feng; Jason H Huang
Journal:  Neurol Res       Date:  2020-07-01       Impact factor: 2.448

2.  An invited commentary on "Impact of the Coronavirus (COVID-19) pandemic on surgical practice-part 1". Impact of the Coronavirus (COVID-19) pandemic on surgical practice: Time to embrace telehealth in surgery.

Authors:  Laura N Purcell; Anthony Charles
Journal:  Int J Surg       Date:  2020-05-19       Impact factor: 6.071

Review 3.  Coronavirus Disease 2019 (COVID-19) and Neurosurgery: Literature and Neurosurgical Societies Recommendations Update.

Authors:  Antonino Germanò; Giovanni Raffa; Filippo Flavio Angileri; Salvatore Massimiliano Cardali; Francesco Tomasello
Journal:  World Neurosurg       Date:  2020-04-30       Impact factor: 2.104

4.  Editorial. Neurosurgery in the storm of COVID-19: suggestions from the Lombardy region, Italy (ex malo bonum).

Authors:  Marco Cenzato; Francesco DiMeco; Marco Fontanella; Davide Locatelli; Franco Servadei
Journal:  J Neurosurg       Date:  2020-04-10       Impact factor: 5.115

5.  The impact of COVID-19 on neurosurgeons and the strategy for triaging non-emergent operations: a global neurosurgery study.

Authors:  Walter C Jean; Natasha T Ironside; Kenneth D Sack; Daniel R Felbaum; Hasan R Syed
Journal:  Acta Neurochir (Wien)       Date:  2020-04-21       Impact factor: 2.216

6.  Scoring System to Triage Patients for Spine Surgery in the Setting of Limited Resources: Application to the Coronavirus Disease 2019 (COVID-19) Pandemic and Beyond.

Authors:  Daniel M Sciubba; Jeff Ehresman; Zach Pennington; Daniel Lubelski; James Feghali; Ali Bydon; Dean Chou; Benjamin D Elder; Aladine A Elsamadicy; C Rory Goodwin; Matthew L Goodwin; James Harrop; Eric O Klineberg; Ilya Laufer; Sheng-Fu L Lo; Brian J Neuman; Peter G Passias; Themistocles Protopsaltis; John H Shin; Nicholas Theodore; Timothy F Witham; Edward C Benzel
Journal:  World Neurosurg       Date:  2020-05-29       Impact factor: 2.104

7.  Trends and outcomes for non-elective neurosurgical procedures in Central Europe during the COVID-19 pandemic.

Authors:  Lukas Grassner; Ondra Petr; Freda M Warner; Michaela Dedeciusova; Andrea Maria Mathis; Daniel Pinggera; Sina Gsellmann; Laura C Meiners; Sascha Freigang; Michael Mokry; Alexandra Resch; Thomas Kretschmer; Tobias Rossmann; Francisco Ruiz Navarro; Andreas Gruber; Mathias Spendel; Peter A Winkler; Franz Marhold; Camillo Sherif; Jonathan P Wais; Karl Rössler; Wolfgang Pfisterer; Manfred Mühlbauer; Felipe A Trivik-Barrientos; Sebastian Rath; Richard Voldrich; Lukas Krska; Radim Lipina; Martin Kerekanic; Jiri Fiedler; Petr Kasik; Vladimir Priban; Michal Tichy; Petr Krupa; Tomas Cesak; Robert Kroupa; Andrej Callo; Pavel Haninec; Daniel Pohlodek; David Krahulik; Alena Sejkorova; Martin Sames; Josef Dvorak; Petr Suchomel; Robert Tomas; Jan Klener; Vilem Juran; Martin Smrcka; Petr Linzer; Miroslav Kaiser; Dusan Hrabovsky; Radim Jancalek; Vincens Kälin; Oliver Bozinov; Cedric Niggli; Carlo Serra; Ramona Guatta; Dominique E Kuhlen; Stefan Wanderer; Serge Marbacher; Alexandre Lavé; Karl Schaller; Clarinde Esculier; Andreas Raabe; John L K Kramer; Claudius Thomé; David Netuka
Journal:  Sci Rep       Date:  2021-03-17       Impact factor: 4.379

8.  Impact of COVID-19 on an Academic Neurosurgery Department: The Johns Hopkins Experience.

Authors:  Adham M Khalafallah; Adrian E Jimenez; Ryan P Lee; Jon D Weingart; Nicholas Theodore; Alan R Cohen; Rafael J Tamargo; Judy Huang; Henry Brem; Debraj Mukherjee
Journal:  World Neurosurg       Date:  2020-05-24       Impact factor: 2.104

9.  Case Volumes and Perioperative Coronavirus Disease 2019 Incidence in Neurosurgical Patients During a Pandemic: Experiences at Two Tertiary Care Centers in Washington, DC.

Authors:  Ehsan Dowlati; Tianzan Zhou; Kwadwo Sarpong; Gnel Pivazyan; Jessica Briscoe; Islam Fayed; William Mualem; Jordan Black; Christopher G Kalhorn; Mani N Nair; Daniel R Felbaum
Journal:  World Neurosurg       Date:  2020-08-07       Impact factor: 2.104

View more
  1 in total

Review 1.  How has the COVID-19 pandemic impacted clinical care and research in Neuro-Oncology?

Authors:  Angus Airth; James R Whittle; James Dimou
Journal:  J Clin Neurosci       Date:  2022-09-08       Impact factor: 2.116

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.